Header Logo

Connection

JOHN FREDERICK DE GROOT to Metformin

Back to Details
This is a "connection" page, showing publications JOHN FREDERICK DE GROOT has written about Metformin.
JOHN FREDERICK DE GROOT
Connection Strength
0.118
Metformin
  1. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Cancer. 2019 02 01; 125(3):424-433.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.